Clinical Trial Assessing the Efficacy and Safety of Dendritic Cell-Based Immunotherapy for Glioblastoma
Clinical trial NCT06749925 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06749925
- Sponsor
- University of Sao Paulo General Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-01
- Primary completion
- 2028-01-01
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.